SCOTT NAGAO: Open Payments
NPI 1205320991 · BRIGHAM CITY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$531 in 27 payments from 15 companies in 2025. Trend: 2023 $472 · 2024 $643 · 2025 $531
Food & beverage: $531
| Company | Payments | Amount |
|---|---|---|
| Indivior Inc. | 4 | $87 |
| PFIZER INC. | 3 | $67 |
| ABBVIE INC. | 2 | $60 |
| GlaxoSmithKline, LLC. | 3 | $52 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $42 |
| Otsuka America Pharmaceutical, Inc. | 2 | $40 |
| Amgen Inc. | 2 | $32 |
| Astellas Pharma US Inc | 1 | $30 |
| Organon LLC | 2 | $21 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
Products named: SUBLOCADE, NURTEC ODT, VRAYLAR, CAPLYTA, REXULTI, TRELEGY ELLIPTA, OTEZLA, Veozah.
Industry payments across UT — which companies pay providers there.
